• Explore /
  • Poster
  • / Dual inhibition of DNA double strand break (DSB) repair and PI3K pathway with BEZ235 (BEZ) to sensitize refractory metastatic (met) triple negative breast cancer (TNBC) to nab paclitaxel/cisplatin (pac/cis) in a patient with an exceptional response (ExRx).

Dual inhibition of DNA double strand break (DSB) repair and PI3K pathway with BEZ235 (BEZ) to sensitize refractory metastatic (met) triple negative breast cancer (TNBC) to nab paclitaxel/cisplatin (pac/cis) in a patient with an exceptional response (ExRx).

Abstract Poster

Authors

Joyce O'Shaughnessy

Joyce O'Shaughnessy

Baylor Sammons Cancer Ctr US Onc, Dallas, TX

Joyce O'Shaughnessy , Virginia A. Espina , Irene Cherni , John D. Carpten , Lance A. Liotta , David W. Craig , Jeff Kiefer , Nicholas N Hoke , Maren K. Levin , Kai Wang , Corinne Ramos

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Breast Cancer Symposium

Session Type

Poster Session

Session Title

Poster Session B: Systemic Therapy, Survivorship, and Health Policy

Track

Systemic Therapy,Local/Regional Therapy,Survivorship and Health Policy

Sub Track

Triple-Negative

Citation

J Clin Oncol 33, 2015 (suppl 28S; abstr 156)

DOI

10.1200/jco.2015.33.28_suppl.156

Abstract #

156

Poster Bd #

J9

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Circulating tumor DNA–based genomic landscape of <em>KRAS</em> wild-type pancreatic adenocarcinoma.

Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.

First Author: Brendon Fusco

First Author: Peter Steinwald

First Author: Tomomi Kashiwada

First Author: Joyce O'Shaughnessy